| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature
|
Hentrich, M.
|
|
2000
|
11 |
2 |
p. 195-200
|
article
|
| 2 |
Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature
|
Hentrich, M.
|
|
|
11 |
2 |
p. 195-200
|
article
|
| 3 |
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer
|
Di Leo, A.
|
|
2000
|
11 |
2 |
p. 169-175
|
article
|
| 4 |
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer
|
Di Leo, A.
|
|
|
11 |
2 |
p. 169-175
|
article
|
| 5 |
Agreement over paclitaxel reinforces BMS monopoly
|
|
|
|
11 |
2 |
p. 124
|
article
|
| 6 |
Amid growing inequalities, an invitation to act
|
|
|
|
11 |
2 |
p. 125-126
|
article
|
| 7 |
A new strategy in unresectable metastatic colorectal cancers
|
Giacchetti, S.
|
|
2000
|
11 |
2 |
p. 243-244
|
article
|
| 8 |
Book review
|
Spataro, V.
|
|
|
11 |
2 |
p. 242
|
article
|
| 9 |
Book review
|
Zanetta, G.
|
|
|
11 |
2 |
p. 238
|
article
|
| 10 |
Book review
|
Timothy, A.
|
|
|
11 |
2 |
p. 130
|
article
|
| 11 |
Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin
|
Greco, F. A.
|
|
2000
|
11 |
2 |
p. 211-215
|
article
|
| 12 |
Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin
|
Greco, F.A.
|
|
|
11 |
2 |
p. 211-215
|
article
|
| 13 |
Contents of the next issue
|
|
|
|
11 |
2 |
p. v
|
article
|
| 14 |
Copyright
|
|
|
|
11 |
2 |
p. iii
|
article
|
| 15 |
Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer
|
Levy-Piedbois, C.
|
|
2000
|
11 |
2 |
p. 157-161
|
article
|
| 16 |
Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer
|
Levy-Piedbois, C.
|
|
|
11 |
2 |
p. 157-161
|
article
|
| 17 |
Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer
|
Kurtz, J. E.
|
|
2000
|
11 |
2 |
p. 229-230
|
article
|
| 18 |
Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer
|
Kurtz, J.E.
|
|
|
11 |
2 |
p. 229-230
|
article
|
| 19 |
Editorial Board
|
|
|
|
11 |
2 |
p. iv
|
article
|
| 20 |
E. E. Kim, E. F. Jackson (eds)., Molecular Imaging in Oncology, PET, MRI, and MRS
|
Timothy, A.
|
|
2000
|
11 |
2 |
p. 130
|
article
|
| 21 |
F. Lawton, M. Friedlander, G. Thomas (eds)., Essentials of Gynaecological Cancer
|
Zanetta, G.
|
|
2000
|
11 |
2 |
p. 238
|
article
|
| 22 |
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study
|
Tondini, C.
|
|
2000
|
11 |
2 |
p. 231-233
|
article
|
| 23 |
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study
|
Tondini, C.
|
|
|
11 |
2 |
p. 231-233
|
article
|
| 24 |
Guillain–Barré syndrome in a patient with non-Hodgkin's lymphoma
|
Re, D.
|
|
2000
|
11 |
2 |
p. 217-220
|
article
|
| 25 |
Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma
|
Re, D.
|
|
|
11 |
2 |
p. 217-220
|
article
|
| 26 |
In this issue
|
|
|
|
11 |
2 |
p. v
|
article
|
| 27 |
Is `one cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms
|
Fizazi, K.
|
|
2000
|
11 |
2 |
p. 133-149
|
article
|
| 28 |
Is ‘one cycle every three or four weeks’ obsolete? A critical review of dose-dense chemotherapy in solid neoplasms
|
Fizazi, K.
|
|
|
11 |
2 |
p. 133-149
|
article
|
| 29 |
L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure
|
Rizzari, C.
|
|
2000
|
11 |
2 |
p. 189-193
|
article
|
| 30 |
L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure
|
Rizzari, C.
|
|
|
11 |
2 |
p. 189-193
|
article
|
| 31 |
Low-dose continuous oral fosfestrol is highly active in `hormone-refractory' prostate cancer
|
Orlando, M.
|
|
2000
|
11 |
2 |
p. 177-181
|
article
|
| 32 |
Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer
|
Orlando, M.
|
|
|
11 |
2 |
p. 177-181
|
article
|
| 33 |
Medical errors kill more than does breast cancer
|
|
|
|
11 |
2 |
p. 126
|
article
|
| 34 |
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
|
Bachelot, T.
|
|
2000
|
11 |
2 |
p. 151-156
|
article
|
| 35 |
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
|
Bachelot, T.
|
|
|
11 |
2 |
p. 151-156
|
article
|
| 36 |
New drugs meeting in Washington: Too demanding for clinicians?
|
|
|
|
11 |
2 |
p. 123
|
article
|
| 37 |
New drugs meeting in Washington: Too demanding for clinicians?; Agreement over paclitaxel reinforces BMS monopoly; US relaxes pressure on developing countries regarding medications; WTO agreement could have threatened European health structures; Progress in euthanasia in Switzerland and Belgium; Amid growing inequalities, an invitation to act; Medical errors kill more than does breast cancer; Perhaps not everyone knows that...
|
|
|
2000
|
11 |
2 |
p. 123-129
|
article
|
| 38 |
Open label, multi-centre phase II study of raltitrexed (`Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck
|
Clarke, S. J.
|
|
2000
|
11 |
2 |
p. 239-241
|
article
|
| 39 |
Open label, multi-centre phase II study of raltitrexed (‘Tomudex’) in patients with inoperable squamous-cell carcinoma of head and neck
|
Clarke, S.J.
|
|
|
11 |
2 |
p. 239-241
|
article
|
| 40 |
Perhaps not everyone knows that...
|
|
|
|
11 |
2 |
p. 126-129
|
article
|
| 41 |
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer
|
Krug, L. M.
|
|
2000
|
11 |
2 |
p. 227-228
|
article
|
| 42 |
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer
|
Krug, L.M.
|
|
|
11 |
2 |
p. 227-228
|
article
|
| 43 |
Progress in euthanasia in Switzerland and Belgium
|
|
|
|
11 |
2 |
p. 125
|
article
|
| 44 |
Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
|
Chester, J. D.
|
|
2000
|
11 |
2 |
p. 235-237
|
article
|
| 45 |
Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
|
Chester, J.D.
|
|
|
11 |
2 |
p. 235-237
|
article
|
| 46 |
Randomised phase II study of cisplatin–etoposide versusinfusional carboplatin in advanced non-small-cell lung cancer and mesothelioma
|
White, S. C.
|
|
2000
|
11 |
2 |
p. 201-206
|
article
|
| 47 |
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma
|
White, S.C.
|
|
|
11 |
2 |
p. 201-206
|
article
|
| 48 |
R. Brown, U. Böger-Brown (eds)., Cytotoxic Drug Resistance Mechanisms
|
Spataro, V.
|
|
2000
|
11 |
2 |
p. 242
|
article
|
| 49 |
Recommendation for surgical treatment of colorectal liver metastascs
|
Bozzetti, F.
|
|
|
11 |
2 |
p. 243
|
article
|
| 50 |
Recommendation for surgical treatment of colorectal liver metastases
|
Bozzetti, F.
|
|
2000
|
11 |
2 |
p. 243
|
article
|
| 51 |
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma
|
Morant, R.
|
|
2000
|
11 |
2 |
p. 183-188
|
article
|
| 52 |
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma
|
Morant, R.
|
|
|
11 |
2 |
p. 183-188
|
article
|
| 53 |
Reversibility of paraneoplastic bilateral diaphragmatic paralysis after nephrectomy for renal cell carcinoma
|
Rijnders, B.
|
|
2000
|
11 |
2 |
p. 221-225
|
article
|
| 54 |
Reversibility of paraneoplastic bilateral diaphragmatic paralysis after nephrectomy for renal cell carcinoma
|
Rijnders, B.
|
|
|
11 |
2 |
p. 221-226
|
article
|
| 55 |
Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study
|
Janinis, J.
|
|
2000
|
11 |
2 |
p. 163-167
|
article
|
| 56 |
Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study
|
Janinis, J.
|
|
|
11 |
2 |
p. 163-167
|
article
|
| 57 |
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG)
|
Sessa, C.
|
|
2000
|
11 |
2 |
p. 207-210
|
article
|
| 58 |
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG)
|
Sessa, C.
|
|
|
11 |
2 |
p. 207-210
|
article
|
| 59 |
Sequential development of liver cirrhosis, hepatocellular carcinoma, essential mixed cryoglobulinemia, and non-Hodgkin's lymphoma in a hepatitis C-positive subject
|
Stroffolini, T.
|
|
2000
|
11 |
2 |
p. 244
|
article
|
| 60 |
Sequential development of liver cirrhosis, hepatocellular carcinoma, essential mixed cryoglobulinemia, and non-Hodgkin's lymphoma in a hepatitis C-positive subject
|
Stroffolini, T.
|
|
|
11 |
2 |
p. 244
|
article
|
| 61 |
Table of Contents
|
|
|
|
11 |
2 |
p. ii-iii
|
article
|
| 62 |
The prognosis of prognostic factors in phase I clinical trials
|
Verweij, J.
|
|
2000
|
11 |
2 |
p. 131-132
|
article
|
| 63 |
The prognosis of prognostic factors in phase I clinical trials
|
Verweij, J.
|
|
|
11 |
2 |
p. 131-132
|
article
|
| 64 |
This letter was referred to the authors, who respond as follows:
|
Giacchetti, S.
|
|
|
11 |
2 |
p. 243-244
|
article
|
| 65 |
US relaxes pressure on developing countries regarding medications
|
|
|
|
11 |
2 |
p. 124
|
article
|
| 66 |
WTO agreement could have threatened European health structures
|
|
|
|
11 |
2 |
p. 124-125
|
article
|
Journal description